191 related articles for article (PubMed ID: 10381045)
1. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome.
Haga HJ; Rygh T
J Rheumatol; 1999 Jun; 26(6):1291-5. PubMed ID: 10381045
[TBL] [Abstract][Full Text] [Related]
2. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
[TBL] [Abstract][Full Text] [Related]
4. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
[TBL] [Abstract][Full Text] [Related]
5. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
Huo AP; Lin KC; Chou CT
Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia in males with systemic lupus erythematosus.
Mok CC; Lau CS; Lee KW; Wong RW
J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
Tishler M; Yaron I; Shirazi I; Yaron M
J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients.
Marcos M; Alvarez F; Brito-Zerón P; Bove A; Perez-De-Lis M; Diaz-Lagares C; Sanchez-Tapias JM; Ramos-Casals M
Autoimmun Rev; 2009 Jun; 8(7):616-20. PubMed ID: 19393197
[TBL] [Abstract][Full Text] [Related]
9. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
11. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
[TBL] [Abstract][Full Text] [Related]
12. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
13. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid levels in Sjögren's syndrome.
Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
Rheumatology (Oxford); 2006 Apr; 45(4):481-4. PubMed ID: 16303821
[TBL] [Abstract][Full Text] [Related]
15. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.
Coates T; Slavotinek JP; Rischmueller M; Schultz D; Anderson C; Dellamelva M; Sage MR; Gordon TP
J Rheumatol; 1999 Jun; 26(6):1301-5. PubMed ID: 10381047
[TBL] [Abstract][Full Text] [Related]
16. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
[TBL] [Abstract][Full Text] [Related]
17. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
Sirois DA; Natelson B
J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
20. Oral and ocular manifestations in Sjögren's syndrome.
Kalk WW; Mansour K; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Roodenburg JL; Nieuw Amerongen AV
J Rheumatol; 2002 May; 29(5):924-30. PubMed ID: 12022351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
